Transplanting islet cells can fix brittle diabetes. Why isn’t it available in the U.S.?
Type 1 diabetes, which affects 1.25 million American children and adults, and more than 20 million people around the world, is a challenging chronic disease caused by the body’s inability to make insulin. Among its most severe forms is brittle diabetes. People with brittle diabetes frequently experi...
Main Authors: | C. Ricordi, A. Japour |
---|---|
Format: | Article |
Language: | English |
Published: |
Verduci Editore
2019-10-01
|
Series: | CellR4 |
Subjects: | |
Online Access: | https://www.cellr4.org/wp-content/uploads/sites/2/2019/10/e2768-Transplanting-islet-cells-can-fix-brittle-diabetes.-Why-isn’t-it-available-in-the-U.S..pdf |
Similar Items
-
Currently Available Non-Balloon Devices
by: Hang Lak Lee
Published: (2018-09-01) -
Gene Editing: The Regulatory Perspective
by: Sarfaraz K. Niazi
Published: (2023-10-01) -
Transplantation or islets of Langerhans: new developments
by: A Caulfield, et al.
Published: (2001-12-01) -
FDA-Approved Fluorinated Heterocyclic Drugs from 2016 to 2022
by: Carla Rizzo, et al.
Published: (2023-04-01) -
Asymmetric Synthesis of US-FDA Approved Drugs over Five Years (2016–2020): A Recapitulation of Chirality
by: Rekha Tamatam, et al.
Published: (2023-02-01)